We are live on ! Find out more
AIM

AIM ImmunoTech

15 hedge funds and large institutions have $294K invested in AIM ImmunoTech in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

180% more capital invested

Capital invested by funds: $105K → $294K (+$189K)

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

25% more funds holding

Funds holding: 1215 (+3)

3.96% more ownership

Funds ownership: 0%3.96% (+4%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AIM Hedge Fund Activity: Q3 2025 in Review

15 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2025, worth a combined $294K — up 180% from $105K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new AIM positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was DRW Securities, opening a new position worth an estimated $194K. The largest seller was Corient Private Wealth, exiting entirely with an estimated $86.5K sold.

  • 15 institutional investors held AIM ImmunoTech (AIM) as of Q3 2025, up from 12 in Q2 2025.
  • Funds reported $294K of AIM ImmunoTech stock for Q3 2025, up 180% quarter-over-quarter.
  • 5 funds opened new AIM ImmunoTech positions in Q3 2025 and 2 closed out, a net change of +3 holders.
  • The largest AIM ImmunoTech buyer in Q3 2025 was DRW Securities, an estimated $194K added.
  • The largest AIM ImmunoTech seller in Q3 2025 was Corient Private Wealth, an estimated $86.5K sold.

Based on aggregated 13F filings for Q3 2025.